Under construction – not a live service
Sign in

NCT03081390Terminated

Migraine and CVD Risk in Women

Mechanisms of Increased Cardiovascular Disease Risk in Women With Migraine

Source: ClinicalTrials.gov · Last updated 6 Oct 2026

Reason given: Investigator transition

Brief summary (registry, in English)

The primary goal of this study is to test the effects of a high-fat, high-carbohydrate mixed meal on candidate modulators of cardiovascular disease risk (inflammation, vascular reactivity, sympathetic nervous system tone, and response to pain) in young adult women with migraine compared with healthy young women. This is study enrolling both cases (women with migraine) and controls (women without migraine), with equal numbers of normal weight and obese women in each group. Participants will undergo a telephone screening and a single day in-person study visit.

Status (registry)
Terminated
Study type
Interventional
Enrollment
23 (actual)
First submitted
16 Feb 2017
Start date
1 Apr 2017
Primary completion date
28 Sept 2026
Lead sponsor
University of Pennsylvania
Diseases
Migraine
NCT number
NCT03081390

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Chronic use of medications, including oral contraceptives
  • Treatment with antibiotics or steroids within the previous 3 months
  • Treatment with NSAIDs within the previous 1 week

Other illness

  • Major medical or psychiatry illness (e.g. diabetes, fibromyalgia, major depression/anxiety)
  • Allergies or sensitivity to any of the ingredients of the meal

Other

  • Smoking (current or former)
  • Pregnant or nursing
  • Inability to fast for 10 hours and/or abstain from caffeine intake for 24 hours
  • Migraine headaches, or headaches other than tension-type headaches with a frequency of 1 or fewer days per month

Who the study is looking for

  • Female 18-35 years of age, inclusive
  • BMI 18.5-24.9 kg/m2, inclusive
  • BMI ≥30 kg/m2
  • Diagnosis of migraine per ICHD-3-beta (1-10 migraine days per month)

Age in the registry: 18 years to 35 years · Sex: Female · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (2)

Sites in registry order. Save your city in your profile to sort them by distance.

SiteCityCountrySite status
University of PennsylvaniaPhiladelphiaUnited StatesUnknown status
Children's Hospital of PhiladelphiaPhiladelphiaUnited StatesUnknown status

Are you the coordinator? Confirm the details

This page is information, not medical advice. Discuss any trial with your doctor.